Date of Award

Summer 7-26-2024

Document Type

Open Access Thesis

Degree Name

Master of Medical Science (MMSc)

First Advisor

Vinita Misra Knight, MD, FAES

Abstract

Epilepsy affects about 70 million people worldwide, making it the world’s second most common neurological disease. The first line treatment for epilepsy are anti-seizure medications, but only two-thirds of patients respond to the first two medications given. We propose a randomized controlled study utilizing intermittent fasting as a therapeutic lifestyle modification as an adjuvant to standard drug therapy for those that experience drug-resistant epilepsy. We will assess the efficacy and safety of intermittent fasting for a period of six months, and statistically determine if there is a significant reduction in the mean frequency of seizures participants experience compared to a control group that is treated with standard drug therapy alone. These results will contribute to current research studies suggesting that intermittent fasting may serve as promising new treatment option for those living with drug-resistant epilepsy.

Comments

This is an open access thesis.

Open Access

This Article is Open Access

Share

COinS